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Introduction
Cerebral vasculitis (CV) comprises the group of noninfectious inflammatory 
vasculitides, such as giant cell arteritis, Takayasu arteritis, Churg-Strauss angiitis, and many 
others. CV can produce a variety of neurologic events, usually in young female patients [1]. 
Neurological symptoms can be variable, but most often seen include a headache, dizziness, 
transient ischemic attack and stroke [2]. CV is the cause of significant morbidity and 
mortality (3-11% of all diagnosed cases) among young patients. Majority of fatalities in CV 
patients are caused by stroke and myocardial infarction.
Case 
Here we present the treatment of a 37-year-old woman with clinical signs of CV, 
possibly due to Takayasu arteritis (precise diagnosis was not possible in this patient since 
the disease affected only intracranial arteries and autopsy was not performed), who for the 
second time developed ischemic stroke of the left cerebral hemisphere, with neurological 
deficit, comprising right-sided hemiparesis and aphasia, which deteriorated despite 
immunosuppression with prednisone (0.3 mg/kg). CT angiography demonstrated occlusion 
of the ophthalmic segment (C6) of the left Internal Carotid Artery (ICA) and critical stenosis 
of the contralateral carotid artery, also in the ophthalmic segment. There were also stenoses 
of the intracranial part of the right vertebral artery and the left Posterior Cerebral Artery 
(PCA).
Considering the severe neurological status of the patient, we decided to attempt 
endovascular revascularization of compromised cerebral arteries. Catheter angiography 
confirmed complete occlusion of the left ICA and critical stenosis of the left PCA. On the 
right side, there was a critical stenosis of the communicating (C7) segment of the ICA with 
the flow toward anterior cerebral artery and contralateral carotid artery. This stenosis 
has progressed when compared to previous CT angiography of this patient, which was 
performed during management of the previous stroke. There was also an occlusion of the 
right middle cerebral artery (MCA) (this territory received inflow from the right vertebral 
artery) and critical stenosis of the intracranial part of the right vertebral artery (Figure 1 
A-D).
An attempt to navigate through occlusion of the left ICA was unsuccessful. Then 
we tried to manage stenosis of the right ICA. Firstly, we advanced the guiding catheter 
Chaperon (MicroVention, Tustin, CA, USA) into the supraclinoid (C4) segment of the ICA, 
afterwards, with the help of microcatheter Rebar®(eV3, Plymouth, MN, USA) we introduced 
Abstract
Cerebral vasculitis that comprises a group of noninfectious inflammatory vasculitides, 
can produce a variety of neurologic events, including also life-threatening ones. In 
this paper we describe the case report of a 37-year-old female patient with cerebral 
vasculitis manifesting as ischemic stroke of the left cerebral hemisphere. Her clinical 
status deteriorated, despite immunosuppression. CT angiography demonstrated several 
occlusions of intracranial arteries. We describe details of endovascular revascularization of 
intracranial arteries in this patient, with focus at the use of the Solitaire stent, which seems 
to be particularly useful in such challenging cases. After endovascular repair this patient 
significantly improved, yet this improvement lasted only 2 months. Then there was a relapse 
of cerebral vasculitis, which finally resulted in fatal outcome. In our opinion, endovascular 
treatment for life-threatening cerebral vasculitis should primarily be seen as a treatment 
that is supplementary to pharmacological management of the autoimmune process. 
Keywords
Angioplasty; Cerebral vasculitis; Stents
J Neurosci Neurosurg Volume: 2.1
Journal Home: https://www.boffinaccess.com/journals/journal-neuroscience-neurosurgery/jnn
2/2
the 0,014”guidewire Transend® (Stryker Neurovascular, Fremont, CA, 
USA) into the left MCA. After the stenosis has been dilatated with the 
2.0 mm angioplastic balloon, which was inflated under the pressure 
of 10 atm for 20 seconds, we advanced the 3 × 30 mm Solitaire™ stent 
(Stryker Neurovascular, Fremont, CA, USA), which was deployed 
at the junction of the ICA with the anterior communicating artery. 
Control angiography revealed a lack of perfusion in this area, despite 
the injection of vasodilators. Therefore, we removed the stent, and 
after confirming that there was flow in the arteries on the left side 
and improved flow in the right MCA, we advanced this stent into 
the MCA and deployed it at the junction of the ICA with the MCA, 
using electrolytic detachment of the device. Angiographic control 
demonstrated the proper positioning of the stent with improved 
inflow to both cerebral hemispheres (Figure 1 E-H).
After endovascular revascularization of the cerebral arteries, 
neurological status of this patient significantly improved. She was 
discharged, with the recommendation of dual antiplatelet therapy 
(aspirin and clopidogrel). This clinical improvement lasted 2 months 
when follow up revealed only slight neurological deficit. Control 
angiography was planned after 1-2 months and any additional 
revascularization in the cerebral vascular territory depended on 
the result of this examination. Further treatment of this patient 
was managed by neurologists. Unfortunately, pharmacotherapy 
with cyclophosphamide, which was aimed at controlling aggressive 
vasculitis, resulted in severe myelosuppression. Management 
with prednisone alone did not prevent from the progression of the 
disease and after 3 months from the endovascular procedure, this 
patient presented with clinical signs of another stroke. Endovascular 
attempts to open occluded stent were not successful and the patient 
died due to profound cerebral ischemia.
Discussion
In patients with CV and lesions critically compromising cerebral 
perfusion, endovascular treatment may offer a bridging therapy, until 
immunosuppression results in an improved status of the diseased 
cerebral arteries. It should be emphasized that such advanced and 
severe lesions as in the above-described case are rarely seen in CV 
patients. Still, they represent an actual therapeutic challenge. An 
initial satisfactory clinical outcome of this patient after endovascular 
revascularization resulted from appropriately chosen endovascular 
armamentarium and good cooperation between neurologists and 
vascular interventionalists [3-6], still it did not affect clinical course 
of severe vasculitis in the cerebral vascular territory. Thus, such an 
interventional treatment should primarily be seen as treatment that is 
supplementary to pharmacological management of the autoimmune 
process.
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Figure 1: A-Occlusion of the left internal carotid artery (Occ. of 
LICA) in C6 segment of the artery, with visible small collaterals; 
B-Critical stenosis of the right internal carotid artery (St. of 
RICA) in its communicating segment coexisting with occlusion 
of the middle cerebral artery (Oc. RMCA), visible flow toward 
the left side; C-Critical stenosis of the right vertebral artery (St. 
RVA) in V4 segment, coexisting with critical stenosis of the left 
posterior cerebral artery (St. LPCA); D-Critical stenosis of the 
right vertebral artery (St. RVA) and visible collaterals to the 
right middle cerebral artery; E-An attempt to navigate through 
occluded left internal carotid artery (Occ. of LICA) with the use 
of supporting microcatheter (MC); F-Inflation of the 2.0/40 mm 
angioplastic balloon inside critically stenosed right internal 
carotid artery (distal part of the guide wire is positioned in the 
left middle cerebral artery); G-Angiography after implantation 
of the Solitaire stent (stent) into the junction of the right 
internal carotid artery with the anterior communicating artery; 
stop of inflow toward the left side is revealed; F-Final results 
after implantation of the Solitaire stent into the junction of the 
internal carotid artery with the middle cerebral artery, with 
good inflow to the middle cerebral artery and improved flow to 
the left cerebral hemisphere.
